Your browser doesn't support javascript.
loading
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma.
Laganà, M; Grisanti, S; Ambrosini, R; Cosentini, D; Abate, A; Zamparini, M; Ferrari, V D; Gianoncelli, A; Turla, A; Canu, L; Terzolo, M; Tiberio, G A M; Sigala, S; Berruti, A.
Affiliation
  • Laganà M; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.
  • Grisanti S; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.
  • Ambrosini R; Radiology Unit, ASST Spedali Civili, Brescia, Italy.
  • Cosentini D; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.
  • Abate A; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Zamparini M; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.
  • Ferrari VD; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.
  • Gianoncelli A; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Turla A; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.
  • Canu L; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
  • Terzolo M; Internal Medicine, Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
  • Tiberio GAM; Surgical Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Sigala S; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Berruti A; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy. Electronic address: alfredo.berruti@unibs.it.
ESMO Open ; 7(2): 100422, 2022 04.
Article in En | MEDLINE | ID: mdl-35272132
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenal Cortex Neoplasms / Adrenocortical Carcinoma Type of study: Etiology_studies Limits: Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenal Cortex Neoplasms / Adrenocortical Carcinoma Type of study: Etiology_studies Limits: Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article Affiliation country: Italy Country of publication: United kingdom